
Abione Tab
Intas Pharmaceuticals Ltd - tablet - 10 S
Standard delivery
Distributor inventory | Tablet
Medically reviewed by Dr. Balaji Krishnan, MBBS · Updated August 2026
Medicines with the same active ingredient and strength as Megatas S 50 Tab.
You are viewing
Megatas S 50 Tab
tablet - 10 S
₹590
₹59.02 per tablet
MSN LABORATORIES · tablet - 10 S · Rx
₹427
₹42.69 per tablet
Solifenacin (5mg) + Mirabegron (50mg)
Begberon S 50mg/5mg Tablet Er is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. In this way, it works to prevent frequent, urgent, or uncontrolled urge of urination.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Megatas S 50 Tablet Er may be taken with or without food, but it is better to take it at a fixed time.

Intas Pharmaceuticals Ltd - tablet - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - tablet - 333 mg - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - capsule - 10 mg - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - capsule - 25 mg - 10 S
Standard delivery
Intas Pharmaceuticals Ltd - tablet - 10 S
Standard delivery
Intas Pharmaceuticals Ltd - tablet - 10 S
Standard delivery
Intas Pharmaceuticals Ltd - 10 S
Standard delivery

Intas Pharmaceuticals Ltd - lotion - 100 ml
Standard delivery
A substitute contains the same active ingredient (salt), in the same strength, as Megatas S 50 Tab. The medicine inside is the same — the brand name, manufacturer and price are what differ.
All medicines sold in India, branded or generic, must meet the quality standards set by the national drug regulator (CDSCO). A lower price does not mean lower quality.
Please confirm with your doctor or pharmacist before switching brands — they will check that the strength and form match your prescription.